{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:50:30Z","timestamp":1784976630644,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","annalsofvascularsurgery.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.avsg.2023.12.100","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T05:50:11Z","timestamp":1712555411000},"page":"93-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Common Criticisms and Rebuttals of the Best Endovascular Versus Best Surgical Therapy in Patients with Chronic Limb-Threatening Ischemia (BEST-CLI) Trial"],"prefix":"10.1016","volume":"107","author":[{"given":"Olivia","family":"D'Angelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Menard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alik","family":"Farber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2023.12.100_bib1","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.1016\/S2214-109X(20)30117-0","article-title":"Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study","volume":"8","author":"Song","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.avsg.2023.12.100_bib2","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib3","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jvs.2014.03.290","article-title":"Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population","volume":"60","author":"Nehler","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJMcp1709326","article-title":"Chronic limb-threatening ischemia","volume":"379","author":"Farber","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2023.12.100_bib5","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jvs.2015.07.065","article-title":"The natural history of untreated severe or critical limb ischemia","volume":"62","author":"Abu Dabrh","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib6","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jcin.2014.06.018","article-title":"Two-year life expectancy in patients with critical limb ischemia","volume":"7","author":"Soga","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2023.12.100_bib7","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jamasurg.2016.2018","article-title":"The current state of critical limb ischemia: a systematic review","volume":"151","author":"Farber","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ahj.2013.12.012","article-title":"Comparative effectiveness of endovascular and surgical revascularization for patients with peripheral artery disease and critical limb ischemia: systematic review of revascularization in critical limb ischemia","volume":"167","author":"Jones","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.avsg.2023.12.100_bib9","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial","volume":"366","author":"Adam","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2023.12.100_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003219","article-title":"Design and rationale of the best endovascular versus best surgical therapy for patients with critical limb ischemia (BEST-CLI) trial","volume":"5","author":"Menard","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2023.12.100_bib11","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa2207899","article-title":"Surgery or endovascular therapy for chronic limb-threatening ischemia","volume":"387","author":"Farber","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2023.12.100_bib12","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ejvs.2018.02.015","article-title":"Editor\u2019s choice - a comparison of clinical outcomes between primary bypass and secondary bypass after failed plain balloon angioplasty in the bypass versus angioplasty for severe ischaemia of the limb (BASIL) trial","volume":"55","author":"Meecham","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib13","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ejvs.2018.09.025","article-title":"Editor\u2019s choice - infrainguinal bypass following failed endovascular intervention compared with primary bypass: a systematic review and meta-analysis","volume":"57","author":"Hossain","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib14","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.jvs.2009.09.044","article-title":"Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia","volume":"50","author":"Conte","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib15","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.jvs.2009.09.045","article-title":"FDA perspective on objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia","volume":"50","author":"Kumar","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"Serruys","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2023.12.100_bib17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ejvs.2023.06.038","article-title":"Editor\u2019s choice - RANDOMisation screening for drug coated or drug eluting device randomised trials among patients undergoing endovascular FemorOPopliteal procedures (RANDOM-STOP study)","volume":"66","author":"Stavroulakis","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib18","article-title":"Contextualizing the BEST-CLI trial results in clinical practice","volume":"2","author":"Butala","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10.1016\/j.avsg.2023.12.100_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.avsg.2022.03.040","article-title":"Outcomes of endovascular-first versus bypass-first approach for patients with chronic limb-threatening ischemia using a medicare-linked database","volume":"85","author":"Mathlouthi","year":"2022","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib20","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jvs.2015.09.063","article-title":"Comparison of open and endovascular treatment of patients with critical limb ischemia in the vascular quality initiative","volume":"63","author":"Siracuse","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.carrev.2021.06.016","article-title":"Overview of the virtual 2021 FDA\u2019s circulatory system devices advisory panel on Lutonix 014 drug-coated percutaneous transluminal angioplasty catheter for below-the-knee lesions in critical limb ischemia","volume":"33","author":"Case","year":"2015","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.avsg.2023.12.100_bib22","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jvs.2018.05.255","article-title":"The BEST-CLI trial is nearing the finish line and promises to be worth the wait","volume":"69","author":"Farber","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib23","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jvs.2018.08.188","article-title":"Comparison of specialties participating in the BEST-CLI trial to specialists treating peripheral arterial disease nationally","volume":"69","author":"Powell","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jvir.2019.10.025","article-title":"Recent trends in clinical setting and provider specialty for endovascular peripheral artery disease interventions for the medicare population","volume":"31","author":"Schramm","year":"2020","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2023.12.100_bib25","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/CIRCRESAHA.114.303505","article-title":"Pharmacological treatment and current management of peripheral artery disease","volume":"116","author":"Bonaca","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.avsg.2023.12.100_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.36014","article-title":"Prescribing of statins after lower extremity revascularization procedures in the US","volume":"4","author":"Singh","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.avsg.2023.12.100_bib27","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.jvs.2020.09.030","article-title":"Registry Assessment of Peripheral Interventional Devices objective performance goals for superficial femoral and popliteal artery peripheral vascular interventions","volume":"73","author":"Bertges","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib28","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jvs.2021.04.067","article-title":"Impact of dual antiplatelet therapy after lower extremity revascularization for chronic limb-threatening ischemia","volume":"74","author":"Ramanan","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib29","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.jvs.2016.05.098","article-title":"Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization","volume":"64","author":"Soden","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00380-021-01937-5","article-title":"Validation of the correlation between angiosome-based target arterial path, mid-term limb-based patency, and the global limb anatomical staging system","volume":"37","author":"Yamada","year":"2022","journal-title":"Heart Vessels"},{"key":"10.1016\/j.avsg.2023.12.100_bib31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jvs.2023.04.034","article-title":"The natural history of chronic limb-threatening ischemia after technical failure of endovascular intervention","volume":"78","author":"Campbell","year":"2023","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejvs.2022.03.044","article-title":"Predictability of the global limb anatomic staging system (GLASS) for technical and limb related outcomes: a systematic review and meta-analysis","volume":"64","author":"Shirasu","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib33","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(23)00462-2","volume":"401","author":"Bradbury","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2023.12.100_bib34","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jvir.2023.01.005","article-title":"Best endovascular versus best surgical therapy in patients with CLI (BEST-CLI) trial: a misleading trial name","volume":"34","author":"Takahashi","year":"2023","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2023.12.100_bib35","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jvs.2019.05.034","article-title":"Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries","volume":"71","author":"Mohapatra","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2023.12.100_bib36","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jamainternmed.2021.2738","article-title":"Longitudinal assessment of safety of femoropopliteal endovascular treatment with paclitaxel-coated devices among Medicare beneficiaries: the SAFE-PAD study","volume":"181","author":"Secemsky","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.avsg.2023.12.100_bib37","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2023.12.100_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znad413","article-title":"The BEST-CLI International Collaborative \u2013 planning a better future for CLTI patients globally","volume":"111","author":"Farber","year":"2024","journal-title":"Br J Surg"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509624001493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509624001493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T22:16:59Z","timestamp":1724797019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509624001493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":38,"alternative-id":["S0890509624001493"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2023.12.100","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Common Criticisms and Rebuttals of the Best Endovascular Versus Best Surgical Therapy in Patients with Chronic Limb-Threatening Ischemia (BEST-CLI) Trial","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2023.12.100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}